Cargando…
Remdesivir: First Approval
The antiviral agent remdesivir (Veklury(®); Gilead Sciences), nucleotide analogue prodrug, has broad-spectrum activity against viruses from several families. Having demonstrated potent antiviral activity against coronaviruses in preclinical studies, remdesivir emerged as a candidate drug for the tre...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459246/ https://www.ncbi.nlm.nih.gov/pubmed/32870481 http://dx.doi.org/10.1007/s40265-020-01378-w |